Knowledge Graphs for Pharma A perspective from the PhUSE Project ‘Clinical Trials Data as RDF’

This talk presents an overview of the philosophy and ongoing work of the PhUSE project "Clinical Trials Results as Resource Description Framework." The team is converting data from the CDISC Study Data Tabulation Model (SDTM) to graph data using an ontology-based approach. The wider implications of this work are discussed, along with deployment strategies within and beyond the industry.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Various ways to implement continuous manufacturing in pharmaceutical development and production

Various ways to implement continuous manufacturing in pharmaceutical development and production
Watch Now

Designing Pharma organisations for success

pharmatimes

Across all industries, people are changing the ways they engage with products, services, and brands. As a result, life sciences companies find themselves challenged to compete for mindshare in an increasingly noisy market. To stay relevant, pharma marketers must re-evaluate their traditional commercial models and address the changing expectations of their customers—at scale. In this free podcast, Aptus Health in association with PharmaTimes, will explore opportunities pharma marketers have to leverage digital communications to create engaging, high-value experiences for their target markets. We’ll also share examples of how the right technologies and approaches drive meaningful outcomes.
Watch Now

The Role of Technology in Precision Diagnosis

HIMSS Media

Individualized, precision medicine is an evolving medical model and is key in helping clinicians reach accurate diagnoses and effective treatment plans for many patients. There are much promise and hype around precision medicine, but implementing and scaling a precision medicine program is challenging. Multiple disciplines must collaborate in order to reach an accurate diagnosis and effective treatment plans. Unfortunately, information is frequently in sales, disparate systems, or lost.
Watch Now

How to Safely Handle Your Antibody Drug Conjugate

Antibody Drug Conjugates (ADCs) have a highly specific mechanism of action which is an advantage for the treatment of several oncology indications. They are made of a highly toxic payload, a linker, and an antibody.
Watch Now

Spotlight

resources